Roisin Stack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roisin Stack has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Barbara M. Ryan
Department of Gastroenterology, Tallaght Hospital, Dublin 24, Ireland
2 shared publications - Glen. A. Doherty
Centre for Colorectal Disease, St. Vincent’s University Hospital, Dublin, Ireland
2 shared publications - Hugh Mulcahy
St. Vincent's University Hospital, Dublin, Ireland
2 shared publications A. Alakkari
From the Department of Gastroenterology, AMNCH, Tallaght, Dublin 24, Ireland
1 shared publicationAlejandra Rodriguez-Sosa
1 shared publication- Alexander Kel
GeneXplain GmbH, Germany
1 shared publication
Latest Publications
- Open Access
- 12 September 2023
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 10 (1) , e001160
Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model study
Objective To evaluate the impact of British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England (BSG/ACPGBI/PHE) 2019 polypectomy surveillance guidelines within a national faecal immunochemical test-based bowel cancer screening (BS) cohort on surveillance activity and detection of pathology by retrospective virtual application. Design A retrospective review of BS colonoscopies performed in 2015–2016 with 5 years prospective follow-up in single institution. Index colonoscopies were selected. Incomplete colonoscopies were excluded. Histology of all resected polyps was reviewed. Surveillance intervals were calculated according to BSG/ACPGBI/PHE 2019 guidelines and compared with pre-existing ‘European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis’ (EUQA 2013). Total number of colonoscopies deferred by virtual implementation of BSG/ACPGBI/PHE 2019 guidelines were calculated. Pathology identified on procedures that would have been deferred was reviewed. Results Total number of index BS colonoscopies performed in 2015–2016 inclusive was 890. 115 were excluded (22 no caecal intubation, 51 inadequate bowel preparation, 56 incomplete polyp clearance). N=509 colonoscopies were scheduled within a 5-year interval following index colonoscopy surveillance rounds based on EUQA guidelines. Overall, volume of surveillance was significantly reduced with retrospective application of BSG/ACPGBI/PHE 2019 guidelines (n=221, pConclusion BSG/ACPGBI/PHE 2019 guidelines safely reduce the burden of colonoscopy demand with acceptable pathology findings on deferred colonoscopies.
- 12 September 2023
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 10 (1) , e001160
Open AccessImplementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model study
Objective To evaluate the impact of British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England (BSG/ACPGBI/PHE) 2019 polypectomy surveillance guidelines within a national faecal immunochemical test-based bowel cancer screening (BS) cohort on surveillance activity and detection of pathology by retrospective virtual application. Design A retrospective review of BS colonoscopies performed in 2015–2016 with 5 years prospective follow-up in single institution. Index colonoscopies were selected. Incomplete colonoscopies were excluded. Histology of all resected polyps was reviewed. Surveillance intervals were calculated according to BSG/ACPGBI/PHE 2019 guidelines and compared with pre-existing ‘European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis’ (EUQA 2013). Total number of colonoscopies deferred by virtual implementation of BSG/ACPGBI/PHE 2019 guidelines were calculated. Pathology identified on procedures that would have been deferred was reviewed. Results Total number of index BS colonoscopies performed in 2015–2016 inclusive was 890. 115 were excluded (22 no caecal intubation, 51 inadequate bowel preparation, 56 incomplete polyp clearance). N=509 colonoscopies were scheduled within a 5-year interval following index colonoscopy surveillance rounds based on EUQA guidelines. Overall, volume of surveillance was significantly reduced with retrospective application of BSG/ACPGBI/PHE 2019 guidelines (n=221, pConclusion BSG/ACPGBI/PHE 2019 guidelines safely reduce the burden of colonoscopy demand with acceptable pathology findings on deferred colonoscopies.
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S103
GOOD FOR THE ENVIRONMENT AND THE POCKET– AN AUDIT OF WASTE GENERATION AND RECYCLING PRACTICES WITHIN AN IRISH ENDOSCOPY UNIT
Aims Ireland has one of the highest greenhouse gas emissions per capita in the EU, at 13.3 metric tons of CO2 equivalent/person. Healthcare accounts for 30% of all public sector greenhouse gas emissions. General waste accounts for almost 60% of waste generated in Irish hospitals. It has been estimated that 1/3 of this could be recycled. A large volume of recyclable waste is generated in Endoscopy, however sustainable practices are not currently promoted. This quality improvement project sought to determine the volume of recyclable waste generated within Endoscopy and whether use of green bin would be a cost-effective strategy. Methods Waste generated by patient-related activity over one week was audited. Non-clinical and clinical waste was weighed and sorted, with the percentage of recyclable waste documented and net cost savings calculated. Reduction in carbon dioxide emissions (CO2e) was calculated. Results In total, 70 non-clinical and 56 clinical waste bags were collected. Median weight for non-clinical waste was 20.1kg (IQR 19.7-21.7kg) and 40kg (IQR 28.8-39.0kg) for clinical waste. Median of 14.1kg (70.5%) of non-clinical and 3kg (7.5%) of clinical waste was recyclable. Disposal cost/tonne summarised in [Table 1]. Net savings of €86.5/week was generated, and a reduction in carbon footprint by 21.7kg CO2e. This equates to a cost saving of €4,498 per year ([Figure 1]), and a reduction in CO2e of 1,128.4kg. Conclusions This audit highlights the impact sustainable practices can have on waste management in Endoscopy. A considerable volume of waste generated can be recycled with significant cost savings and reductions in CO2e. Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S103
GOOD FOR THE ENVIRONMENT AND THE POCKET– AN AUDIT OF WASTE GENERATION AND RECYCLING PRACTICES WITHIN AN IRISH ENDOSCOPY UNIT
Aims Ireland has one of the highest greenhouse gas emissions per capita in the EU, at 13.3 metric tons of CO2 equivalent/person. Healthcare accounts for 30% of all public sector greenhouse gas emissions. General waste accounts for almost 60% of waste generated in Irish hospitals. It has been estimated that 1/3 of this could be recycled. A large volume of recyclable waste is generated in Endoscopy, however sustainable practices are not currently promoted. This quality improvement project sought to determine the volume of recyclable waste generated within Endoscopy and whether use of green bin would be a cost-effective strategy. Methods Waste generated by patient-related activity over one week was audited. Non-clinical and clinical waste was weighed and sorted, with the percentage of recyclable waste documented and net cost savings calculated. Reduction in carbon dioxide emissions (CO2e) was calculated. Results In total, 70 non-clinical and 56 clinical waste bags were collected. Median weight for non-clinical waste was 20.1kg (IQR 19.7-21.7kg) and 40kg (IQR 28.8-39.0kg) for clinical waste. Median of 14.1kg (70.5%) of non-clinical and 3kg (7.5%) of clinical waste was recyclable. Disposal cost/tonne summarised in [Table 1]. Net savings of €86.5/week was generated, and a reduction in carbon footprint by 21.7kg CO2e. This equates to a cost saving of €4,498 per year ([Figure 1]), and a reduction in CO2e of 1,128.4kg. Conclusions This audit highlights the impact sustainable practices can have on waste management in Endoscopy. A considerable volume of waste generated can be recycled with significant cost savings and reductions in CO2e. Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 21 March 2017
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2017, 1-4
Post-ERCP Emphysematous Cholecystitis in a Young Woman: A Rare and Potentially Fatal Complication
A 45-year-old woman with suspected Functional Biliary Sphincter Disorder (FBSD) developed Clostridium perfringens related emphysematous cholecystitis after ERCP. A low index of suspicion for emphysematous cholecystitis in this young, otherwise healthy woman led to a significant delay in making the correct diagnosis, and air in the gallbladder was wrongly attributed to a possible gallbladder perforation. ERCP is associated with significant risks, particularly in patients with FBSD, where diagnostic uncertainty renders the balance of risk versus benefit even more critical. Post-ERCP emphysematous cholecystitis secondary to Clostridium perfringens is a rare but potentially fatal complication.
- 21 March 2017
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2017, 1-4
Open AccessPost-ERCP Emphysematous Cholecystitis in a Young Woman: A Rare and Potentially Fatal Complication
A 45-year-old woman with suspected Functional Biliary Sphincter Disorder (FBSD) developed Clostridium perfringens related emphysematous cholecystitis after ERCP. A low index of suspicion for emphysematous cholecystitis in this young, otherwise healthy woman led to a significant delay in making the correct diagnosis, and air in the gallbladder was wrongly attributed to a possible gallbladder perforation. ERCP is associated with significant risks, particularly in patients with FBSD, where diagnostic uncertainty renders the balance of risk versus benefit even more critical. Post-ERCP emphysematous cholecystitis secondary to Clostridium perfringens is a rare but potentially fatal complication.
- Open Access
- 11 June 2016
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 109 (8) , 553-554
CMV pneumonitis in an immunosuppressed Crohn's disease patient
On day 2 of treatment, she required intubation and admission to ICU. She had a stormy ICU admission requiring hemodialysis for maintenance of fluid and electrol
- 11 June 2016
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 109 (8) , 553-554
Open AccessCMV pneumonitis in an immunosuppressed Crohn's disease patient
On day 2 of treatment, she required intubation and admission to ICU. She had a stormy ICU admission requiring hemodialysis for maintenance of fluid and electrol